Bank of America’s Cogentix Medical, Inc. CGNT Stock Holding History

Bank of America’s Portfolio CGNT Stock Details CGNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-6,879	Closed	-$26K	–	7592
2018 Q1	$26K	Buy	6,879 +6,153	+848%	+$19.3K	﹤0.01%	6300
2017 Q4	$2K	Sell	726 -60	-8%	-$173	﹤0.01%	6890
2017 Q3	$2K	Buy	786 +60	+8%	+$131	﹤0.01%	6902
2017 Q2	$1K	Hold	726	–	–	﹤0.01%	6880
2017 Q1	$1K	Sell	726 -77	-10%	-$152	﹤0.01%	6910
2016 Q4	$2K	Buy	803 +74	+10%	+$151	﹤0.01%	6872
2016 Q3	$1K	Sell	729 -28	-4%	-$36	﹤0.01%	7033
2016 Q2	$1K	Sell	757 -1,969	-72%	-$1.94K	﹤0.01%	7052
2016 Q1	$3K	Buy	+2,726	New	+$3.06K	﹤0.01%	6736

Bank of America's CGNT Position: Q2 2018 in Review

Bank of America sold out of Cogentix Medical, Inc. (CGNT) in Q2 2018, closing a stake of 6,879 shares — an estimated $26K sold.

Bank of America first reported a position in CGNT in Q1 2016 and held it in 9 quarters. The position peaked at $26K in Q1 2018. 0 funds tracked by Wall St. Rank hold CGNT as of Q2 2018.

Bank of America reported no remaining Cogentix Medical, Inc. position as of Q2 2018 after selling out during the quarter.
Bank of America sold 6,879 Cogentix Medical, Inc. shares in Q2 2018, an estimated $26K.
Bank of America first reported a position in Cogentix Medical, Inc. in Q1 2016 and held it in 9 quarters.
Bank of America's Cogentix Medical, Inc. position peaked at $26K in Q1 2018.
0 funds tracked by Wall St. Rank held Cogentix Medical, Inc. as of Q2 2018.

Based on Bank of America's 13F filing for Q2 2018, filed 14 Aug 2018.